TY - JOUR
T1 - Inhibitory dysfunction in frontotemporal dementia
T2 - A review
AU - O'Callaghan, Claire
AU - Hodges, John R.
AU - Hornberger, Michael
PY - 2013/4
Y1 - 2013/4
N2 - Failure of inhibitory control is an early and consistent feature in patients suffering from frontotemporal dementia (FTD). This appears because of their pervasive ventromedial prefrontal atrophy - particularly in the orbitofrontal cortex - which has been linked to inhibitory dysfunction in studies on human and monkey lesions. However, the range of measures currently available to assess inhibitory processes in FTD is limited, and, as such, inhibitory dysfunction in FTD remains relatively underexplored. Subjective caregiver questionnaires are useful for defining disinhibition as it manifests behaviorally; however, endorsement of symptoms can vary largely across patients as it is contingent on the perceptiveness of the caregiver. The few objective neuropsychological tasks that tap directly into inhibitory functioning have potential, although they mostly rely on intact language and semantics, which can confound performance in FTD patients. An emergent possibility is to explore inhibitory functioning in FTD through nonverbal experimental tasks. Adaptation of such experimental tasks into clinical tools is a promising avenue for exploring one of the earliest behavioral features in FTD patients and concomitantly tap into their prevalent orbitofrontal cortex dysfunction. We suggest that improved characterization of early inhibitory dysfunction may facilitate more accurate diagnosis of FTD.
AB - Failure of inhibitory control is an early and consistent feature in patients suffering from frontotemporal dementia (FTD). This appears because of their pervasive ventromedial prefrontal atrophy - particularly in the orbitofrontal cortex - which has been linked to inhibitory dysfunction in studies on human and monkey lesions. However, the range of measures currently available to assess inhibitory processes in FTD is limited, and, as such, inhibitory dysfunction in FTD remains relatively underexplored. Subjective caregiver questionnaires are useful for defining disinhibition as it manifests behaviorally; however, endorsement of symptoms can vary largely across patients as it is contingent on the perceptiveness of the caregiver. The few objective neuropsychological tasks that tap directly into inhibitory functioning have potential, although they mostly rely on intact language and semantics, which can confound performance in FTD patients. An emergent possibility is to explore inhibitory functioning in FTD through nonverbal experimental tasks. Adaptation of such experimental tasks into clinical tools is a promising avenue for exploring one of the earliest behavioral features in FTD patients and concomitantly tap into their prevalent orbitofrontal cortex dysfunction. We suggest that improved characterization of early inhibitory dysfunction may facilitate more accurate diagnosis of FTD.
KW - Alzheimer disease
KW - disinhibition
KW - frontotemporal dementia
KW - inhibitory dysfunction
KW - orbitofrontal cortex
UR - http://www.scopus.com/inward/record.url?scp=84878875068&partnerID=8YFLogxK
U2 - 10.1097/WAD.0b013e318265bbc9
DO - 10.1097/WAD.0b013e318265bbc9
M3 - Article
C2 - 22828322
AN - SCOPUS:84878875068
VL - 27
SP - 102
EP - 108
JO - Alzheimer Disease & Associated Disorders
JF - Alzheimer Disease & Associated Disorders
SN - 0893-0341
IS - 2
ER -